Bernardita Méndez, PhD
B.S. and M.S. in Biology, Universidad de Chile; Ph.D. in Cell Biology, Universidad Católica de Chile; postdoctoral training in the Department of Biochemistry, University of California, Berkeley. Her strong biotechnology background includes more than a decade with Chiron Corporation, Emeryville, California, as Vice President, Regulatory and Quality Affairs, corporate officer and member of the executive committee. In this capacity, Dr. Mendez was responsible for the regulatory approval of many biotech-derived diagnostics, vaccines and therapeutics by health authorities on a world-wide basis, as well as for the filing and prosecution of patents in USA and abroad.
Dr. Méndez is a Professor at Universidad Andrés Bello and Universidad Católica de Chile. She serves as a Board member in several profit and non-profit organizations, including Fundación Chile. She was a member of the National Council for Innovation and Competitiveness, a national advisory board on innovation, convened by President Michelle Bachelet (2006-2010).